Search Results for:
-
GLYCOMED RECEIVES PATENT NOTICE
Last week the Alameda, Calif., company (NASDAQ:GLYC) announced it had won an orphan drug designation for Galardin and expects to file in mid-1992 to start clinical trialsBioWorld Today | Thursday, January 9, 1992 -
IMRE ARTHRITIS TREATMENT TRIALS APPROVED
on Wednesday said it has received Food and Drug Administration approval to begin clinical trials of its Prosorba column for treatment of patients with rheumatoid arthritisBioWorld Today | Thursday, January 9, 1992 -
IMMUNEX PRESIDENT PREDICTS LOWER EARNINGS
The company will also begin clinical trials in midyear of tumor necrosis factor in septic shock and cachexia...To support an approval, the company also will begin a large clinical trial this year or next using conventional end pointsBioWorld Today | Tuesday, January 7, 1992 -
PDGF SHOWS PROMISE AGAINST BEDSORES
The first clinical trial of Amgen Inc.'s platelet-derived growth factor (PDGF) shows the recombinant protein can help heal bedsoresBioWorld Today | Tuesday, January 7, 1992 -
THE YEAR AHEAD: MARKET SUCCESS WON'T DETER DEALS
The 24 smaller companies she tracks each have about $40 million to $45 million in cash, and they will need more money as they head into clinical trials...Several biotech companies are now showing that they can move products through clinical trials for well under $100 million, he saidBioWorld Today | Tuesday, January 7, 1992 -
FDA'S FAST TRACK: APPROACH WITH CAUTION
And Burlington noted that the FDA already has taken some steps to accelerate approvals by using "a more forgiving approach" to the use of some surrogate markers in clinical trialsBioWorld Today | Thursday, December 26, 1991 -
ATS FILES FOR 2 MILLION-SHARE OFFERING
In November, the Food and Drug Administration approved expansion of ATS' clinical trials of Dermagraft, a living dermal replacement for use in burn treatment, to 24 burn centersBioWorld Today | Thursday, December 26, 1991 -
CHIEF SCIENTIFIC OFFICER LEAVES LIDAK
At the meeting, according to Katz, the directors also accepted another consultant's recommendation that the company proceed with clinical trials of Lidakol and consider submitting an additional investigational new drug application for the topical application of Lidakol to burnsBioWorld Today | Monday, December 23, 1991 -
COSTS CUT BY REDUCING CEREDASE DOSES
Only a formal clinical trial comparing a low dose with a high dose in patients who have undergone splenectomy will prove that the burden and disruption of three treatments per week are truly worthwhile," the NIH group and colleagues at Massachusetts General Hospital concludedBioWorld Today | Thursday, December 19, 1991 -
ALLELIX RAISES $21.8 MILLION IN IPO
The Mississauga, Ontario, developer of products for tissue repair and inflammation said the money would be used primarily for preclinical product development, clinical trials and construction of a pilot production facilityBioWorld Today | Thursday, December 19, 1991 -
DEPRENYL SEEKS APPROVAL FOR PHASE II
has filed for Canadian approval to begin testing a drug for Alzheimer's disease in two clinical trialsBioWorld Today | Thursday, December 19, 1991 -
JOINT VENTURE FOR HEPATITIS B TRIALS
said its Asian licensee, SciClone Pharmaceuticals Inc., has formed a joint venture company to launch a Phase III clinical trial of Thymosin alpha 1 to treat chronic hepatitis BBioWorld Today | Thursday, December 19, 1991 -
NEORX RECEIVES FINANCING PAYMENT
NeoRx has three clinical trials in progress and has filed for Food and Drug Administration marketing approval of two OncoTrac imaging products to detect metastatic melanoma and small cell lung cancer. (c) 1997 American Health ConsultantsBioWorld Today | Thursday, December 19, 1991 -
SYNERGEN RAISES $225.4M IN FINANCING
The funds will be used primarily for research and development and clinical trials, the company said...Through 1993, the company expects to spend about $45 million for preclinical and clinical trials, said spokeswoman Debra BannisterBioWorld Today | Wednesday, December 18, 1991 -
MS THERAPY EFFECTIVE IN MOUSE MODEL
The company is also in preclinical testing with an analogous molecule designed to treat myasthenia gravis, and expects to start clinical trials of this compound by JanuaryBioWorld Today | Wednesday, December 18, 1991 -
GENTA RAISES $25 MILLION IN IPO
In August, Genta filed to begin Phase I/II clinical trials of its antisense compound to treat chronic myelogenous leukemiaBioWorld Today | Wednesday, December 18, 1991 -
GILEAD FILES FOR 3 MILLION-SHARE IPO
Gilead, which doesn't yet have drugs in clinical trials, has focused its research in three related areas that have broadened its focus beyond antisenseBioWorld Today | Tuesday, December 17, 1991 -
EJ FINANCIAL BUYS 30% OF CARBOMED
The drug is now in animal trials, and CarboMed hopes to begin clinical trials next year to treat solid tumors...Jeffrey Sollender, vice president of EJ Financial, said the company hopes that the first-round funding will be sufficient to carry CarboMed through the first phase of clinical trialsBioWorld Today | Monday, December 16, 1991 -
GENENTECH BUYS STAKE IN CELLULAR
Its lead product, NeuroCrib for the treatment of Parkinson's disease, is expected to enter clinical trials next yearBioWorld Today | Monday, December 16, 1991 -
FDA PANEL RECOMMENDS FACTOR VIII
Baxter presented data on 42 patients after 15 months of clinical trials, while Miles' study of 72 PUPs began in January 1989BioWorld Today | Friday, December 13, 1991
Category
Current Filters
- xclinical trials
Related Keywords
Categories
- x BioWorld Today (9737)
- x BioWorld International (1950)
- x BioWorld Insight (1198)
- x Bio Perspectives (295)
- x State of the Industry Report (131)
- x BioWorld Genomics Review (58)
- x Top 25 Drug Report (43)
- x BioWorld Snapshots (29)
- x Biotech Innovations (17)
- x Market-Leading Biotech Drugs (12)
- x RNAi Report (11)
- x BioWorld Phase III Report (7)
- x Executive Compensation Report (4)
- x Recorded (4)
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.